Additional publications


Oncology / Immuno-oncology


Interventional studies

Bolinder J, Ljunggren O, Johansson L, Wilding J, Langkilde AM, Sjöström CD, Sugg J, Parikh S. Dapagliflozin maintains glycaemic control while reducing weight and body fat mass over 2 years in patients with type 2 diabetes mellitus inadequately controlled on metformin. Diabetes Obes Metab. 2013 Aug 1.

Ljunggren Ö, Bolinder J, Johansson L, Wilding J, Langkilde AM, Sjöström CD, Sugg J, Parikh S. Dapagliflozin has no effect on markers of bone formation and resorption or bone mineral density in patients with inadequately controlled type 2 diabetes mellitus on metformin. Diabetes Obes Metab. 2012 Nov;14(11):990-9

Eriksson JW, Jansson PA, Carlberg B, Hägg A, Kurland L, Svensson MK, Ahlström H, Ström C, Lönn L, Ojbrandt K, Johansson L, Lind L.
Hydrochlorothiazide, but not Candesartan, aggravates insulin resistance and causes visceral and hepatic fat accumulation: the mechanisms for the diabetes preventing effect of Candesartan (MEDICA) Study.
Hypertension. 2008 Dec;52(6):1030-7.

Bolinder J, Ljunggren Ö, Kullberg J, Johansson L, Wilding J, Langkilde AM, Sugg J, Parikh S.
Effects of dapagliflozin on body weight, total fat mass, and regional adipose tissue distribution in patients with type 2 diabetes mellitus with inadequate glycemic control on metformin.
J Clin Endocrinol Metab. 2012 Mar;97(3):1020-31

Rosqvist F, Iggman D, Kullberg J, Cedernaes J, Johansson HE, Larsson A, Johansson L, Ahlström H, Arner P, Dahlman I, Risérus U.
Overfeeding polyunsaturated and saturated fat causes distinct effects on liver and visceral fat accumulation in humans.
Diabetes. 2014 Jul;63(7):2356-68

Bjermo H, Iggman D, Kullberg J, Dahlman I, Johansson L, Persson L, Berglund J, Pulkki K, Basu S, Uusitupa M, Rudling M, Arner P, Cederholm T, Ahlström H, Risérus U. Effects of n-6 PUFAs compared with SFAs on liver fat, lipoproteins, and inflammation in abdominal obesity: a randomized controlled trial. Am J Clin Nutr. 2012 May;95(5):1003-12

Kullberg J, Sundbom M, Haenni A, Freden S, Johansson L, Börnert P, Ahlström A, Ahlström H, Karlsson A. Gastric bypass promotes more lipid mobilization than a similar weight loss induced by low-calorie diet. J Obes. 2011;2011:959601.

Johansson L, Roos M, Kullberg J, Weis J, Ahlström H, Sundbom M, Edén Engström B, Karlsson FA. Lipid mobilization following Roux-en-Y gastric bypass examined by magnetic resonance imaging and spectroscopy. Obes Surg. 2008 Oct;18(10):1297-304

Schwitter J, Wacker CM, van Rossum AC, Lombardi M, Al-Saadi N, Ahlstrom H, Dill T, Larsson HB, Flamm SD, Marquardt M, Johansson L. MR-IMPACT: comparison of perfusion-cardiac magnetic resonance with single-photon emission computed tomography for the detection of coronary artery disease in a multicentre, multivendor, randomized trial. Eur Heart J. 2008 Feb;29(4):480-9.

Method development studies

Berglund J, Ahlström H, Johansson L, Kullberg J. Two-point dixon method with flexible echo times. Magn Reson Med. 2011 Apr;65(4):994-1004.

Hansen T, Wanhainen A, Sörensen J, Johansson L. Lymph nodes as a potential pitfall in carotid plaque imaging with FDG-PET/CT. Atherosclerosis. 2011 Mar;215(1):247-8.

Hjelmgren O, Johansson L, Prahl U, Schmidt C, Fredén-Lindqvist J, Bergström GM.
A study of plaque vascularization and inflammation using quantitative contrast-enhanced US and PET/CT.
Eur J Radiol. 2014 Jul;83(7):1184-9.

Hjelmgren O, Holdfeldt P, Johansson L, Fagerberg B, Prahl U, Schmidt C, Bergström GM.
Identification of vascularised carotid plaques using a standardized and reproducible technique to measure ultrasound contrast uptake.
Eur J Vasc Endovasc Surg. 2013 Jul;46(1):21-8

Berglund J, Johansson L, Ahlström H, Kullberg J.
Three-point Dixon method enables whole-body water and fat imaging of obese subjects.
Magn Reson Med. 2010 Jun;63(6):1659-68.

Kullberg J, Johansson L, Ahlström H, Courivaud F, Koken P, Eggers H, Börnert P. Automated assessment of whole-body adipose tissue depots from continuously moving bed MRI: a feasibility study. J Magn Reson Imaging. 2009 Jul;30(1):185-93

Kullberg J, Ortiz-Nieto F, Johansson L. Reproducibility of hepatic triglyceride content assessment in normals using localized magnetic resonance spectroscopy. Diabetes Obes Metab. 2009 May;11(5):516-8.

Kullberg J, Ahlström H, Johansson L, Frimmel H. Automated and reproducible segmentation of visceral and subcutaneous adipose tissue from abdominal MRI. Int J Obes (Lond). 2007 Dec;31(12):1806-17. Epub 2007 Jun 26.

Eriksson O, Espes D, Selvaraju RK, Jansson E, Antoni G, Sörensen J, Lubberink M, Biglarnia A, Eriksson JW, Sundin A, Ahlström H, Eriksson B, Johansson L, Carlsson PO, Korsgren O. Positron Emission Tomography ligand [11C]5-Hydroxy-Tryptophan can be used as a surrogate marker for the human endocrine pancreas. Diabetes. 2014 May 21

Eriksson O, Selvaraju RK, Johansson L, Eriksson JW, Sundin A, Antoni G, Sörensen J, Eriksson B, Korsgren O. Quantitative imaging of serotonergic biosynthesis and degradation in the endocrine pancreas. J Nucl Med. 2014 Mar;55(3):460-5.

Selvaraju RK, Velikyan I, Johansson L, Wu Z, Todorov I, Shively J, Kandeel F, Korsgren O, Eriksson O. In vivo imaging of the glucagonlike peptide 1 receptor in the pancreas with 68Ga-labeled DO3A-exendin-4. J Nucl Med. 2013 Aug;54(8):1458-63

Eriksson O, Jahan M, Johnström P, Korsgren O, Sundin A, Halldin C, Johansson L. In vivo and in vitro characterization of [18F]-FE-(+)-DTBZ as a tracer for beta-cell mass. Nucl Med Biol. 2010 Apr;37(3):357-63

Cross sectional studies

Silver HJ, Niswender KD, Kullberg J, Berglund J, Johansson L, Bruvold M, Avison MJ, Welch EB. Comparison of gross body fat-water magnetic resonance imaging at 3 Tesla to dual-energy X-ray absorptiometry in obese women. Obesity (Silver Spring). 2013 Apr;21(4):765-74.

Lundberg C, Johansson L, Barbier CE, Lind L, Ahlström H, Hansen T. Total atherosclerotic burden by whole body magnetic resonance angiography predicts major adverse cardiovascular events. Atherosclerosis. 2013 May;228(1):148-52

Barbier CE, Nylander R, Themudo R, Ahlström H, Lind L, Larsson EM, Bjerner T, Johansson L. Prevalence of unrecognized myocardial infarction detected with magnetic resonance imaging and its relationship to cerebral ischemic lesions in both sexes.J Am Coll Cardiol. 2011 Sep 20;58(13):1372-7.

Mirza MA, Hansen T, Johansson L, Ahlström H, Larsson A, Lind L, Larsson TE. Relationship between circulating FGF23 and total body atherosclerosis in the community. Nephrol Dial Transplant. 2009 Oct;24(10):3125-31.

Wanhainen A, Themudo R, Ahlström H, Lind L, Johansson L. Thoracic and abdominal aortic dimension in 70-year-old men and women–a population-based whole-body magnetic resonance imaging (MRI) study. J Vasc Surg. 2008 Mar;47(3):504-12

Barbier CE, Bjerner T, Johansson L, Lind L, Ahlström H. Myocardial scars more frequent than expected: magnetic resonance imaging detects potential risk group. J Am Coll Cardiol. 2006 Aug 15;48(4):765-71.

Oncology / Immuno-oncology


Mosavi F, Wassberg C, Selling J, Molin D, Ahlström H. Whole-body diffusion-weighted MRI and 18FDG PET/CT can discriminate between different lymphoma subtypes. Clinical Radiology 2015 Nov;70(11):1229-36

Selvaraju RK, Bulenga TN, Espes D, Lubberink M, Sörensen J, Eriksson B, Estrada S, Velikyan I, Eriksson O. Dosimetry of [68Ga]Ga-DO3A-VS-Cys40-Exendin-4 in rodents, pigs, non-human primates and human – repeated scanning in human is possible. Am J Nucl Med Mol Imaging. 2015;5:259-269.

Velikyan I, Bulenga TN, Selvaraju RK, Lubberink M, Espes D, Rosenström U, Eriksson O. Dosimetry of [177Lu]-DO3A-VS-Cys40-Exendin-4  – impact on the feasibility of insulinoma internal radiotherapy. Am J Nucl Med Mol Imaging. 2015;5:109-26.

Selvaraju RK, Velikyan I, Asplund V, Johansson L, Wu Z, Todorov I, Shively J, Kandeel F, Eriksson B, Korsgren O, Eriksson O. Pre-clinical Evaluation of [68Ga]Ga-DO3A-VS-Cys40-Exendin-4 For Imaging of Insulinoma. Nucl Med Biol. 2014;41:471-6.

Eriksson O, Velikyan I, Selvaraju RK, Kandeel F, Johansson L, Antoni G, Eriksson B, Sörensen J, Korsgren O. Detection of Metastatic Insulinoma by Positron Emission Tomography with [68Ga]Exendin-4 – a case report. J Clin Endocrinol Metab. 2014;99:1519-24.


Loskog A, Maleka A, Mangsbo S, Svensson E, Lundberg C, Nilsson A, Krause J, Agnarsdóttir M, Sundin A, Ahlström H, Tötterman TH, Ullenhag G. Immunostimulatory AdCD40L gene therapy combined with low-dose cyclophosphamide in metastatic malignant melanoma patients. Br J Cancer. 2016 Apr 12;114(8):872-80.

Ullenhag GJ, Sadeghi AM, Carlsson B, Ahlström H, Mosavi F, Wagenius G, Tötterman TH. Adoptive T-cell therapy for malignant melanoma patients with TILs obtained by ultrasound-guided needle biopsy. Cancer Immunol Immunother 2012 May;61(5):725-32

Eriksson O, Sadeghi A, Carlsson B, Eich T, Lundgren T, Nilsson B, Tötterman T, Korsgren O, Sundin A. Distribution of adoptively transferred porcine T-lymphoblasts tracked by [18F]FDG and Position Emission Tomography. Nucl Med Biol. 2011 Aug;38(6);827-833.

Featured publications